Credit Suisse AG Has $57.41 Million Position in Cigna Corporation (NYSE:CI)
Credit Suisse AG boosted its stake in shares of Cigna Corporation (NYSE:CI) by 2.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 391,927 shares of the health services provider’s stock after buying an additional 10,180 shares during the period. Credit Suisse AG owned 0.15% of Cigna Corporation worth $57,414,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in CI. Private Trust Co. NA bought a new stake in Cigna Corporation during the first quarter valued at approximately $205,000. Bank of Montreal Can increased its stake in Cigna Corporation by 21.8% in the first quarter. Bank of Montreal Can now owns 267,090 shares of the health services provider’s stock valued at $39,126,000 after buying an additional 47,800 shares during the last quarter. National Pension Service increased its stake in Cigna Corporation by 2.1% in the first quarter. National Pension Service now owns 194,155 shares of the health services provider’s stock valued at $28,657,000 after buying an additional 3,935 shares during the last quarter. Gulf International Bank UK Ltd increased its stake in Cigna Corporation by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 79,827 shares of the health services provider’s stock valued at $11,693,000 after buying an additional 1,085 shares during the last quarter. Finally, American Investment Services Inc. increased its stake in Cigna Corporation by 10.1% in the first quarter. American Investment Services Inc. now owns 2,183 shares of the health services provider’s stock valued at $320,000 after buying an additional 200 shares during the last quarter. Institutional investors own 86.95% of the company’s stock.
Cigna Corporation (NYSE CI) traded up 0.75% during trading on Thursday, reaching $176.05. 1,568,153 shares of the company’s stock traded hands. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $177.24. The firm has a 50 day moving average of $170.76 and a 200 day moving average of $157.68. The firm has a market capitalization of $45.07 billion, a PE ratio of 23.50 and a beta of 0.46.
Cigna Corporation (NYSE:CI) last announced its earnings results on Friday, May 5th. The health services provider reported $2.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.33. Cigna Corporation had a return on equity of 16.07% and a net margin of 6.53%. The business had revenue of $10.39 billion for the quarter, compared to analyst estimates of $10.11 billion. During the same quarter last year, the firm earned $2.46 EPS. Cigna Corporation’s revenue for the quarter was up 5.1% compared to the same quarter last year. Equities analysts forecast that Cigna Corporation will post $9.79 EPS for the current year.
WARNING: “Credit Suisse AG Has $57.41 Million Position in Cigna Corporation (NYSE:CI)” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/08/03/credit-suisse-ag-has-57-41-million-stake-in-cigna-corporation-nyseci-updated-updated-updated.html.
Several research analysts recently issued reports on CI shares. Deutsche Bank AG started coverage on shares of Cigna Corporation in a report on Wednesday, April 5th. They set a “buy” rating and a $172.00 target price for the company. CIBC lifted their price objective on shares of Cigna Corporation from $174.00 to $185.00 and gave the company an “outperform” rating in a report on Thursday, June 15th. Wells Fargo & Company reaffirmed a “market perform” rating and issued a $174.00 price objective (up previously from $163.00) on shares of Cigna Corporation in a report on Monday, June 19th. Oppenheimer Holdings, Inc. lifted their price objective on shares of Cigna Corporation from $174.00 to $185.00 and gave the company an “outperform” rating in a report on Thursday, June 15th. Finally, ValuEngine raised shares of Cigna Corporation from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. Cigna Corporation has an average rating of “Buy” and an average target price of $176.61.
In other Cigna Corporation news, EVP Nicole S. Jones sold 20,312 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total transaction of $3,250,732.48. Following the transaction, the executive vice president now owns 44,737 shares of the company’s stock, valued at approximately $7,159,709.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jane E. Md Henney sold 600 shares of the business’s stock in a transaction that occurred on Monday, July 24th. The stock was sold at an average price of $174.14, for a total value of $104,484.00. The disclosure for this sale can be found here. In the last three months, insiders sold 219,558 shares of company stock worth $37,135,665. 1.30% of the stock is owned by insiders.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.